Search by
On December 4, 2025, Hims & Hers Health, Inc. has completed its acquisition of Livewell, a Canadian digital health platform focused on weight loss treatments, marking the company's entry into the Canadian market. The acquisition, funded entirely with cash from Hims & Hers' balance sheet, enables the US-based health and wellness platform to expand beyond its existing operations in the United States and Europe. Financial terms of the transaction were not disclosed, and no legal advisors were identified in the announcement.
The strategic acquisition positions Hims & Hers to launch a comprehensive weight loss program in Canada next year, coinciding with the anticipated first availability of generic semaglutide globally. The expansion addresses significant market demand, as nearly two-thirds of Canadian adults are overweight or living with obesity, while facing limited access to affordable treatments.
To support Canadian operations, Hims & Hers has appointed Austin Kouri as General Manager of Canada and Dr. Sandy Van as Chief Medical Officer in Canada. The company aims to leverage Livewell's established local presence and its own digital platform to provide accessible, personalized healthcare to Canadians. Hims & Hers indicated plans for continued international expansion into additional specialties and markets.
Parties
Company
Hims & Hers Health, Inc.
Company
Medici Technologies Inc. (dba Livewell)
Deal Type
Merger & AcquisitionIndustry
HealthcareTransaction
Undisclosed/ConfidentialDeal Status
ClosedClosing Date
04 December 2025